Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:COVH - FR0000060303 - REIT

23.8 EUR
+0.9 (+3.93%)
Last: 1/12/2026, 7:00:00 PM
Fundamental Rating

4

Overall COVH gets a fundamental rating of 4 out of 10. We evaluated COVH against 42 industry peers in the Diversified REITs industry. COVH has only an average score on both its financial health and profitability. COVH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year COVH was profitable.
COVH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: COVH reported negative net income in multiple years.
In the past 5 years COVH always reported a positive cash flow from operatings.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

COVH's Return On Assets of 2.88% is in line compared to the rest of the industry. COVH outperforms 59.52% of its industry peers.
Looking at the Return On Equity, with a value of 5.87%, COVH is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
COVH has a Return On Invested Capital (3.67%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COVH is in line with the industry average of 3.45%.
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROIC 3.67%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

COVH's Profit Margin of 78.86% is amongst the best of the industry. COVH outperforms 88.10% of its industry peers.
COVH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 101.41%, COVH belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
COVH's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 101.41%
PM (TTM) 78.86%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COVH is destroying value.
COVH has about the same amout of shares outstanding than it did 1 year ago.
COVH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, COVH has a worse debt to assets ratio.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that COVH is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of COVH (1.02) is better than 66.67% of its industry peers.
The Debt to FCF ratio of COVH is 12.71, which is on the high side as it means it would take COVH, 12.71 years of fcf income to pay off all of its debts.
COVH's Debt to FCF ratio of 12.71 is in line compared to the rest of the industry. COVH outperforms 54.76% of its industry peers.
COVH has a Debt/Equity ratio of 0.70. This is a neutral value indicating COVH is somewhat dependend on debt financing.
The Debt to Equity ratio of COVH (0.70) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Altman-Z 1.02
ROIC/WACC0.68
WACC5.39%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

COVH has a Current Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
COVH's Current ratio of 1.16 is amongst the best of the industry. COVH outperforms 88.10% of its industry peers.
A Quick Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
COVH's Quick ratio of 1.16 is amongst the best of the industry. COVH outperforms 88.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 242.64% over the past year.
The earnings per share for COVH have been decreasing by -12.16% on average. This is quite bad
Looking at the last year, COVH shows a decrease in Revenue. The Revenue has decreased by -5.26% in the last year.
COVH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.29% yearly.
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

Based on estimates for the next years, COVH will show a small growth in Earnings Per Share. The EPS will grow by 0.90% on average per year.
COVH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.55% yearly.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.25, which indicates a rather expensive current valuation of COVH.
Compared to the rest of the industry, the Price/Earnings ratio of COVH is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.25. COVH is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 13.81 indicates a correct valuation of COVH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COVH indicates a slightly more expensive valuation: COVH is more expensive than 61.90% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.98, COVH is valued a bit cheaper.
Industry RankSector Rank
PE 17.25
Fwd PE 13.81
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COVH indicates a somewhat cheap valuation: COVH is cheaper than 61.90% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COVH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 16.25
EV/EBITDA 16.85
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.73
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

COVH has a Yearly Dividend Yield of 6.52%, which is a nice return.
Compared to an average industry Dividend Yield of 4.99, COVH pays a bit more dividend than its industry peers.
COVH's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 6.52%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

19.17% of the earnings are spent on dividend by COVH. This is a low number and sustainable payout ratio.
DP19.17%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (1/12/2026, 7:00:00 PM)

23.8

+0.9 (+3.93%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22 2025-10-22
Earnings (Next)02-16 2026-02-16
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.76B
Revenue(TTM)260.60M
Net Income(TTM)205.50M
Analysts82.86
Price Target18.67 (-21.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.52%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.25
Fwd PE 13.81
P/S 14.43
P/FCF 16.25
P/OCF 10.28
P/B 1.07
P/tB 1.19
EV/EBITDA 16.85
EPS(TTM)1.38
EY5.8%
EPS(NY)1.72
Fwd EY7.24%
FCF(TTM)1.46
FCFY6.15%
OCF(TTM)2.32
OCFY9.73%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.73
PEG (5Y)N/A
Graham Number26.22
Profitability
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROCE 4.15%
ROIC 3.67%
ROICexc 4.06%
ROICexgc 4.3%
OM 101.41%
PM (TTM) 78.86%
GM N/A
FCFM 88.79%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexgc growth 3Y33.75%
ROICexgc growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Debt/EBITDA 6.96
Cap/Depr 151.01%
Cap/Sales 51.57%
Interest Coverage 4.11
Cash Conversion 103.55%
Profit Quality 112.6%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.02
F-Score5
WACC5.39%
ROIC/WACC0.68
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.66%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.4%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.44%
OCF growth 3Y30.01%
OCF growth 5Y4.76%

COVIVIO HOTELS SACA / COVH.PA FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


What is the valuation status of COVIVIO HOTELS SACA (COVH.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Overvalued.


How profitable is COVIVIO HOTELS SACA (COVH.PA) stock?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for COVH stock?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 17.25 and the Price/Book (PB) ratio is 1.07.


Can you provide the expected EPS growth for COVH stock?

The Earnings per Share (EPS) of COVIVIO HOTELS SACA (COVH.PA) is expected to grow by 3.01% in the next year.